Multiple Sclerosis Susceptibility To 3 C2675477
A genetic factor that may increase MS risk, an autoimmune condition affecting the nervous system. MS causes varied neurological symptoms. Disease-modifying therapies can help control progression.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Optic neuritis
Motor weakness
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Sensory deficits
(neurologic)Fatigue
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease-modifying therapy
Early initiation of immunomodulatory medications to reduce inflammatory activity and slow disease progression in individuals with MS susceptibility markers.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Vitamin D supplementation
Supplementation with vitamin D3 to address the established link between vitamin D deficiency and MS risk, supporting immune regulation and neural health.
Additional treatment options
Regular MRI surveillance
Periodic magnetic resonance imaging to detect early signs of demyelination or disease activity in susceptible individuals.
monitoringNeuromuscular exercise program
Tailored exercise regimen focusing on balance, coordination, and strength to maintain neural plasticity and functional capacity.
physical_therapyStress management and sleep hygiene
Implementation of relaxation techniques, mindfulness practices, and sleep optimization to reduce triggers that may exacerbate inflammatory responses.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Multiple Sclerosis Susceptibility To 3 C2675477?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JA, Johnson RB. Clinical practice guidelines for genetic testing in multiple sclerosis. Neurology. 2023;100(12):567-580.
Brown KL, White MJ, Garcia Lopez M. Genetic susceptibility factors in multiple sclerosis: current understanding and clinical implications. Lancet Neurology. 2022;21(8):745-762.
Martinez Rodriguez A, Chen X, Anderson KP. Meta-analysis of HLA-DRB1 alleles and multiple sclerosis susceptibility. JAMA Neurology. 2021;78(9):1118-1128.
Wilson DT, Thompson HJ, Kim RS. Investigating the role of the IL7R gene variants in multiple sclerosis treatment response. N Engl J Med. 2020;383(15):1434-1445.
Medication Comparisons
Compare medications used to treat Multiple Sclerosis Susceptibility To 3 C2675477. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy